---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-108467"
form_type: "8-K"
ticker: "BRTX"
cik: "0001505497"
company_name: "BioRestorative Therapies, Inc."
filed_at: "2026-10-09T20:05:40+00:00"
generated_at: "2026-10-12T15:11:44.946217+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# BioRestorative Therapies appoints Donald J. Currie as Class I director, filling Katharyn Field vacancy

## Summary
- Currie, 65, appointed effective Oct 7, 2026, to serve until the 2027 annual meeting; fills the vacancy from Katharyn Field's resignation effective Aug 31, 2026.
- Board deemed Currie independent under Nasdaq listing rules and Exchange Act Rule 10A-3; he joins the Compensation and Nominating & Corporate Governance Committees.
- Compensation: CAD $2,000 per month cash fee payable in arrears plus expense reimbursement; he will not participate in the standard non-employee director compensation program.
- Currie has served as CEO and a director of Hillcrest Energy Technologies (CSE: HEAT; OTCQB: HLRTF) since February 2010, with 30+ years in energy and public-company financing.
- No arrangement or understanding with any other person regarding the appointment; no family relationships with directors or officers and no Item 404(a) reportable transactions.

## SEC filing metadata
- accession: 0001213900-26-108467
- form_type: 8-K
- ticker: BRTX
- cik: 0001505497
- company_name: BioRestorative Therapies, Inc.
- filed_at: 2026-10-09T20:05:40+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1505497/000121390026108467/0001213900-26-108467-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1505497/000121390026108467/ea0305784-8k_biore.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-108467
- JSON: https://secwatch.observer/filing/0001213900-26-108467.json
- Plain text: https://secwatch.observer/filing/0001213900-26-108467.txt

## Key facts
- Executive change
  Katharyn Field resigned as Director at BioRestorative Therapies, Inc..
  - Action: resigned
  - Role: Director
  source text: previously reported resignation of Katharyn Field as a director effective August 31, 2026.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1505497/000121390026108467/0001213900-26-108467-index.htm
- Executive change
  Donald J. Currie was appointed as Class I director at BioRestorative Therapies, Inc..
  - Action: appointed
  - Role: Class I director
  source text: On October 7, 2026, the Board of Directors (the “ Board ”) of BioRestorative Therapies, Inc. (the “ Company ”) appointed Donald J. Currie as a Class I director of the Company, effective immediately, to fill the vacancy created by the previously reported resignation of Katharyn Field as a director effective August 31, 2026.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1505497/000121390026108467/0001213900-26-108467-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.